Alternatives to Biogen
Biogen is a Biotech tool: global biotechnology company pioneering innovative medicines for complex neurological, neuropsychiatric, and rare diseases. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Biogen
Ipsen3.0 out of 5 (1)Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.
BiotechMedTechUpdated 30 Jun 2026
Tahoe TherapeuticsNot ratedDeveloping novel therapies for neurological disorders.
BiotechMedTechUpdated 26 Sept 2026
Anamnesis BioNot ratedDeveloping novel therapeutics for neurodegenerative diseases using advanced biological insights.
BiotechHealthTechUpdated 1 Jun 2026
Eli Lilly and CompanyNot ratedGlobal pharmaceutical company focused on developing and manufacturing medicines.
BiotechMedTechUpdated 9 Jul 2026
Davinci NeuroscienceNot ratedDeveloping a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.
Life SciencesNeurotechUpdated 22 Sept 2026
Prophet BioNot ratedProphet Bio is a biotech startup focused on developing novel therapeutics for neurodegenerative diseases.
Life SciencesBiotechUpdated 1 Jun 2026
PfizerNot ratedA global pharmaceutical and biotechnology corporation developing innovative medicines and vaccines for various therapeutic areas.
BiotechnologyPharmaceuticalsUpdated 1 May 2026
SobiNot ratedSobi is a specialized international biopharmaceutical company focused on developing innovative therapies for rare diseases.
Updated 1 May 2026
Adaptive BiotechnologiesNot ratedLeveraging the adaptive immune system to diagnose and treat disease.
BiotechHealthTechUpdated 1 Jul 2026- LELexeo Therapeutics3.0 out of 5 (1)
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
BiotechMedTechUpdated 1 May 2026
Harmony Biosciences HoldingsNot ratedBiopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.
BiotechMedTechUpdated 30 Aug 2026
Amicus TherapeuticsNot ratedBiotechnology company focused on developing treatments for rare metabolic diseases.
BiotechMedTechUpdated 13 Sept 2026
AlectorNot ratedBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
BiotechMedTechUpdated 1 May 2026
Avidity BiosciencesNot ratedClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
BiotechDrug DiscoveryUpdated 13 Sept 2026
RezoluteNot ratedBiopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.
BiotechMedTechUpdated 25 Sept 2026
Orchard TherapeuticsNot ratedGene therapy company developing treatments for rare inherited diseases.
BiotechMedTechUpdated 28 May 2026
Dren BioNot ratedBiopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.
BiotechDrug DiscoveryUpdated 7 Sept 2026
Alto Neuroscience5.0 out of 5 (1)Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.
BiotechMedTechUpdated 29 Sept 2026
Editas MedicineNot ratedA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
BiotechMedTechUpdated 23 Jun 2026
Intellia TherapeuticsNot ratedA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
BiotechMedTechUpdated 30 Aug 2026
Showing the 20 closest matches. See the rest on the Biogen profile.